Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXB6
|
ENSG00000108511.10 | homeobox B6 |
PRRX2
|
ENSG00000167157.11 | paired related homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PRRX2 | hg38_v1_chr9_+_129665603_129665672 | -0.33 | 6.2e-02 | Click! |
HOXB6 | hg38_v1_chr17_-_48604959_48605000 | -0.26 | 1.4e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 79.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
5.0 | 55.2 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
3.6 | 10.9 | GO:0021758 | caudate nucleus development(GO:0021757) putamen development(GO:0021758) |
3.6 | 54.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
3.6 | 21.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
2.8 | 19.9 | GO:0021764 | amygdala development(GO:0021764) |
2.8 | 16.8 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
2.3 | 6.9 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.2 | 11.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
2.2 | 10.8 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
2.1 | 6.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.0 | 8.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.0 | 57.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.0 | 13.8 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.9 | 7.6 | GO:0051795 | embryonic nail plate morphogenesis(GO:0035880) positive regulation of catagen(GO:0051795) |
1.8 | 7.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
1.8 | 1.8 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
1.8 | 5.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
1.6 | 25.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
1.5 | 17.0 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
1.5 | 6.1 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
1.5 | 4.6 | GO:0044007 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
1.5 | 6.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
1.5 | 6.0 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
1.4 | 7.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
1.4 | 1.4 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.3 | 10.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
1.2 | 20.5 | GO:1903764 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) |
1.2 | 18.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.1 | 3.4 | GO:0021763 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
1.1 | 9.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
1.1 | 8.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.1 | 4.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
1.1 | 6.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
1.1 | 5.5 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
1.0 | 8.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.0 | 10.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 10.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 14.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 7.6 | GO:0061709 | reticulophagy(GO:0061709) |
0.9 | 11.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 2.8 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
0.9 | 9.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.9 | 6.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 15.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.9 | 12.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 2.6 | GO:1904638 | cellular response to nitrite(GO:0071250) response to nitrite(GO:0080033) positive regulation of mitochondrial DNA metabolic process(GO:1901860) glomerular visceral epithelial cell apoptotic process(GO:1903210) regulation of glomerular visceral epithelial cell apoptotic process(GO:1904633) positive regulation of glomerular visceral epithelial cell apoptotic process(GO:1904635) response to resveratrol(GO:1904638) cellular response to resveratrol(GO:1904639) positive regulation of progesterone biosynthetic process(GO:2000184) |
0.8 | 18.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.8 | 1.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.8 | 5.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 5.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 35.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 6.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.8 | 8.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.8 | 8.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.7 | 11.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 2.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 3.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 5.0 | GO:0018032 | protein amidation(GO:0018032) |
0.7 | 4.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 3.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.7 | 9.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.7 | 7.8 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.7 | 2.0 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.6 | 5.7 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.6 | 57.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.6 | 52.6 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.6 | 1.8 | GO:0042245 | RNA repair(GO:0042245) |
0.6 | 6.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 1.8 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.6 | 35.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.6 | 6.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 10.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 15.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 5.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.6 | 4.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 14.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 2.4 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.6 | 3.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.6 | 3.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 4.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.6 | 9.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 2.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 4.1 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
0.5 | 3.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 6.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 34.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.5 | 7.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 2.9 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.5 | 2.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 5.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.5 | 5.1 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.5 | 6.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 2.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.5 | 2.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 2.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 6.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 23.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.4 | 4.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.4 | 10.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 5.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 0.8 | GO:0086004 | regulation of cardiac muscle cell contraction(GO:0086004) |
0.4 | 6.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.4 | 8.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 7.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 1.6 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
0.4 | 2.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 2.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.4 | 16.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 3.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 2.0 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.4 | 4.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 2.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.4 | 3.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.4 | 2.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 8.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 3.3 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.4 | 1.5 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.4 | 1.5 | GO:0060529 | ectoderm and mesoderm interaction(GO:0007499) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.4 | 1.1 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
0.4 | 2.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.4 | 8.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 2.4 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 1.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 0.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.3 | 7.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 6.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 6.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 27.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 3.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.3 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.3 | 6.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.3 | 2.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 4.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 2.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.6 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 1.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 3.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 2.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.3 | 8.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.2 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.3 | 1.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 6.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 3.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 1.1 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.3 | 1.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.3 | 2.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.3 | 2.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 1.7 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.3 | 1.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.3 | 0.8 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 10.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 0.8 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.3 | 21.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 2.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 1.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.3 | 12.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.8 | GO:0048561 | establishment of organ orientation(GO:0048561) |
0.3 | 18.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.8 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.3 | 4.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 24.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 2.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.2 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.2 | 4.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 2.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 11.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 2.3 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.2 | 2.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 6.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.2 | 1.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.5 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 1.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 2.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.2 | 0.9 | GO:0036269 | swimming behavior(GO:0036269) |
0.2 | 1.1 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 0.6 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.2 | 1.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 1.5 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 11.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 3.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 1.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 1.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 6.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 1.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 2.6 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.2 | 0.4 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.2 | 11.1 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 1.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 5.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.0 | GO:1990523 | bone regeneration(GO:1990523) |
0.2 | 1.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 1.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.2 | 1.5 | GO:1901558 | response to metformin(GO:1901558) |
0.2 | 1.5 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 2.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 30.9 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 3.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 1.1 | GO:0015692 | lead ion transport(GO:0015692) |
0.2 | 2.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.7 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 1.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 3.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 13.6 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.2 | 2.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 1.1 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.2 | 2.0 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
0.2 | 3.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 7.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 6.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 3.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 7.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 3.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 3.0 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.2 | 1.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 3.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 30.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 2.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 2.2 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.6 | GO:0016119 | carotene metabolic process(GO:0016119) |
0.2 | 3.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.8 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.2 | 1.1 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.2 | 1.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.2 | 1.7 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.9 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.2 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 1.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 6.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.3 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.1 | 8.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 5.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.1 | 4.4 | GO:0007628 | adult walking behavior(GO:0007628) |
0.1 | 1.0 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 1.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 1.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 5.2 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.5 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.1 | 2.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.9 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 2.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 3.8 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.5 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.1 | 4.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.7 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.1 | 7.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 7.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.9 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 8.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 2.5 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.1 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 1.2 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 1.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.9 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 2.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 11.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 1.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 0.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 1.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 4.3 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 2.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 6.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 2.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 1.4 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 1.5 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.5 | GO:1900108 | growth plate cartilage chondrocyte proliferation(GO:0003419) negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 1.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 7.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 18.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.5 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.6 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.1 | 9.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 1.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 1.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.1 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 1.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 8.4 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 2.5 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 2.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.6 | GO:2000124 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 2.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 1.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 2.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 5.8 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 1.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 2.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.4 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 1.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 1.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 3.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 19.2 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 2.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 1.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 2.2 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 2.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 1.3 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 3.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 1.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 2.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 2.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of steroid hormone biosynthetic process(GO:0090032) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 6.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 12.2 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 1.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 2.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 3.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 1.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 1.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 1.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.4 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 6.5 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 1.5 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) regulation of positive thymic T cell selection(GO:1902232) |
0.0 | 8.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.0 | 0.8 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 3.9 | GO:0030832 | regulation of actin polymerization or depolymerization(GO:0008064) regulation of actin filament length(GO:0030832) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 3.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.4 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.0 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 1.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 2.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 4.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 1.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.5 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.2 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.0 | 0.4 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.0 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 1.3 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.7 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 6.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 1.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.0 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 1.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.6 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 1.3 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 5.1 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 1.1 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.0 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 31.0 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
2.4 | 21.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.7 | 8.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
1.6 | 6.6 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
1.6 | 26.9 | GO:0016013 | syntrophin complex(GO:0016013) |
1.4 | 5.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.4 | 62.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
1.4 | 4.1 | GO:0014802 | terminal cisterna(GO:0014802) |
1.2 | 11.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.2 | 4.7 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.1 | 7.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
1.0 | 7.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.0 | 2.9 | GO:0097444 | spine apparatus(GO:0097444) |
0.9 | 16.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 20.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 8.2 | GO:0031673 | H zone(GO:0031673) |
0.9 | 20.2 | GO:0032982 | myosin filament(GO:0032982) |
0.9 | 2.6 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.8 | 6.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 4.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 6.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.7 | 8.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 15.5 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.7 | 2.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.6 | 43.8 | GO:0031430 | M band(GO:0031430) |
0.6 | 5.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.6 | 17.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 1.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 15.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 34.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 22.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 4.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.5 | 82.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 3.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.5 | 8.5 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 8.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 7.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 10.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 11.9 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.3 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.4 | 2.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.4 | 7.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 137.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 2.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 4.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 3.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 9.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 4.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 7.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 4.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.3 | 4.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 14.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 100.7 | GO:0098794 | postsynapse(GO:0098794) |
0.3 | 56.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.3 | 5.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 83.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 16.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 2.3 | GO:0055028 | cortical microtubule(GO:0055028) |
0.2 | 2.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 8.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 38.1 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.4 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.7 | GO:0060342 | photoreceptor inner segment membrane(GO:0060342) |
0.2 | 2.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.0 | GO:0071149 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.2 | 0.6 | GO:0005592 | collagen type XI trimer(GO:0005592) |
0.2 | 2.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 1.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.2 | 1.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 2.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 4.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 9.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 5.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 6.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 7.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 2.6 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 28.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.1 | 3.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 17.9 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 2.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 5.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 1.2 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 22.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 10.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 2.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.1 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 6.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.8 | GO:0031674 | I band(GO:0031674) |
0.1 | 29.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 37.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 4.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 13.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 7.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 9.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 4.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 9.8 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0044207 | eukaryotic 48S preinitiation complex(GO:0033290) translation initiation ternary complex(GO:0044207) |
0.0 | 1.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 8.3 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 2.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 11.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 10.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 3.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) Flemming body(GO:0090543) |
0.0 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 2.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 10.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 27.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
2.5 | 14.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.4 | 55.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.3 | 6.9 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.1 | 8.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
2.1 | 20.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
2.0 | 20.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.6 | 30.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.6 | 51.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.5 | 4.5 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
1.5 | 51.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.4 | 12.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 10.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.3 | 6.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.3 | 11.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.3 | 10.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 18.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.2 | 3.6 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
1.2 | 4.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.1 | 8.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.1 | 5.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.1 | 20.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 4.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 2.8 | GO:0036326 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
0.9 | 6.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.9 | 22.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 10.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 25.0 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.8 | 4.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.8 | 4.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.8 | 33.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 29.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 5.0 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.7 | 6.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.7 | 2.0 | GO:0099530 | G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.7 | 2.0 | GO:0008940 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.6 | 3.8 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.6 | 30.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 10.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.6 | 5.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 6.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 12.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 2.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.5 | 23.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 2.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.5 | 1.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.5 | 15.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 11.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 4.0 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 15.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 4.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 12.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 68.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.4 | 2.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 3.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 13.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 7.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 3.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.4 | 1.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 5.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 7.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 11.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 21.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 99.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.4 | 1.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 2.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 1.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 1.1 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.4 | 1.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.3 | 1.7 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.3 | 10.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 12.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.0 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.3 | 0.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 2.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 2.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 2.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 7.5 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 18.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 4.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 10.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 5.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.3 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 3.3 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 8.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 30.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 2.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 9.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 6.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.2 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.2 | 9.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 3.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.9 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 9.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 7.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.6 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 2.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 1.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 3.1 | GO:0022821 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.2 | 3.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 6.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 4.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 59.9 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 0.8 | GO:0030379 | neurotensin receptor activity, non-G-protein coupled(GO:0030379) |
0.2 | 0.4 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 1.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 2.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 1.1 | GO:0015087 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 1.3 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.2 | 3.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 62.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 1.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 5.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 1.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 8.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.9 | GO:0017018 | myosin phosphatase activity(GO:0017018) myosin-light-chain-phosphatase activity(GO:0050115) |
0.2 | 11.3 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 42.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 2.0 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.2 | 4.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 2.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.9 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.2 | 7.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 2.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 18.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.8 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 35.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 28.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 15.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 5.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 6.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 7.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.1 | 0.5 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.9 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 1.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 8.9 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 2.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 2.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 2.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 3.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 31.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 1.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.5 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 1.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 7.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.4 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.8 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.5 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 4.1 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 13.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 1.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 7.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 23.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 2.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 3.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 3.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 15.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0030305 | heparanase activity(GO:0030305) |
0.0 | 2.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 4.1 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 71.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 9.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 29.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 15.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 27.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 26.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 22.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 7.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 27.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 2.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 6.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 19.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 5.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 7.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 4.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 7.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 9.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 10.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 4.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 7.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 5.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 2.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 13.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 7.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 7.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 4.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 3.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 3.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 2.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 7.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 63.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.1 | 33.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.8 | 87.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 25.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 1.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.6 | 33.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 13.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 18.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 31.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 25.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 16.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 16.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 21.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 7.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 9.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 3.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 22.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 7.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 10.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 6.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 44.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 8.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 25.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 5.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 2.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 2.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 5.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 6.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 5.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 3.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 5.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 2.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 26.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.6 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 1.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 3.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 3.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 3.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 6.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 5.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 5.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |